Highlight Therapeutics SL Revenue and Competitors
Estimated Revenue & Valuation
- Highlight Therapeutics SL's estimated annual revenue is currently $2.8M per year.
- Highlight Therapeutics SL's estimated revenue per employee is $155,000
Employee Data
- Highlight Therapeutics SL has 18 Employees.
- Highlight Therapeutics SL grew their employee count by -10% last year.
Highlight Therapeutics SL's People
| Name | Title | Email/Phone |
|---|
Highlight Therapeutics SL Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Highlight Therapeutics SL?
Highlight, formerly known as Bioncotech Therapeutics S.L, is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology. Its lead drug candidate BO-112 is a best-in-class RNA-based therapy which has been demonstrated to initiate a powerful immune response, leveraging a unique multi-target approach to turn ‘cold' tumors ‘hot' and therefore visible to the immune system. It has the potential to rescue patients who are resistant to current checkpoint inhibitor therapy. BO-112 is currently being investigated in a range of clinical trials as a monotherapy and in combination with checkpoint inhibitors. In addition to in-house research, Highlight Therapeutics has a number of external collaborators, including Merck & Co and UCLA.
keywords:N/A
N/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Highlight Therapeutics SL News
Highlight Therapeutics S. L., info highlighttherapeutics.com. Marisol Quintero, CEO. Mo PR Advisory, Tel: +44 (0) 7876...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 18 | -40% | N/A |
#2 | $2.4M | 18 | -33% | N/A |
#3 | $1.4M | 18 | -18% | N/A |
#4 | $1.4M | 18 | -10% | $406.5M |
#5 | $1.4M | 18 | -33% | $173M |